WO1984001174A1 - Identification of microorganisms - Google Patents

Identification of microorganisms Download PDF

Info

Publication number
WO1984001174A1
WO1984001174A1 PCT/US1983/001029 US8301029W WO8401174A1 WO 1984001174 A1 WO1984001174 A1 WO 1984001174A1 US 8301029 W US8301029 W US 8301029W WO 8401174 A1 WO8401174 A1 WO 8401174A1
Authority
WO
WIPO (PCT)
Prior art keywords
dna
microorganisms
microorganism
species
sample
Prior art date
Application number
PCT/US1983/001029
Other languages
French (fr)
Inventor
Dyann Fergus Wirth
Diane Macmahon-Pratt
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of WO1984001174A1 publication Critical patent/WO1984001174A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6893Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa

Definitions

  • This invention relates to identification of a specific microorganism in a specimen or sample containing whole microorganisms and pertains more specifically to the diagnosis of diseases characterized by a localized concentration of infectious organisms in tissue, particularly the skin, or in a biological ' fluid, particularly blood; still more particularly it pertains to the rapid diagnosis of such diseases as leishmaniasis, malaria, trypanosomiasis, babesiasis, and herpesvirus diseases.
  • leishmaniasis (caused by several different species of Leishmania)
  • malaria (caused by several different species of Plasmodium)
  • trypanosomiasis (caused by several different species of Trypansoma)
  • babesiasis (caused by various species of Babesia)
  • the diseases caused by various members of the herpesvirus family are leishmaniasis (caused by several different species of Leishmania)
  • malaria caused by several different species of Plasmodium)
  • trypanosomiasis (caused by several different species of Trypansoma)
  • babesiasis (caused by various species of Babesia)
  • the diseases caused by various members of the herpesvirus family The severity and pathogenicity of the disease in each case depends upon the specific identity of the infectious organism. Both the
  • Sty iro treatment for the disease and the subsequent medical follow up depend upon rapid, accurate identification of the infecting species.
  • Techniques currently widely used for identification of strains of microorganisms and diagnosis and identification of the infecting species in the case of diseases are time-consuming, involving the isolation and cultivation of the microorganism, e.g. the infectious organism and are often unsuccessful because of serious technical difficulties. Delay in identification is particularly serious in the case of those diseases which are endemic to areas where medical services are not readily available.
  • Ostrow et al.. Virology, Vol. 108, 21-27 (1981) described extraction and purification of virus from wart tissue, extraction and purification of DNA from the purified virus, and treatment of the purified DNA with restriction enzyme followed by hybridization with labelled DNA from known organisms.
  • species of microorganisms can be identified in samples of products or in samples of infected tissue or of biological fluid such as blood from infected mammals by immobilizing DNA from said sample on a solid support, subjecting said immobilized DNA to hybridization with a labeled specimen of species-specific non-cross-hybridizing DNA from a known organism, and determining whether hybridization occurs.
  • kinetoplast DNA is a species-specific non-cross-hybridizing DNA which can be used effectively as the labelled probe or hybridizing agent.
  • a sample of the product or culture suspected to contain an undesired microorganism, or a sample of infected tissue from a skin lesion or a sample of infected blood, both of which contain whole organisms of the infecting species is simply touched momentarily to any conventional solid support for immobilizing DNA, such as
  • OM ⁇ i ⁇ SNATl ⁇ diazobenzyloxymethyl paper a nitrocellulose filter, or a solid DNA support sold under the trade name "Gene Screen", treated with aqueous alkali (preferably at least 0.2 M) to expose the DNA from within the organism, and the alkali removed by washing.
  • the sample DNA thus immobilized in a small localized zone of the support and containing all of the DNA of the sample, is then subjected to hybridization with a labelled specimen of species-specific non-cross-hybridizing DNA from an authentic known specimen of an individual species or subspecies of the microorganism.
  • OMPI require shorter times, but much higher temperatures tend to destroy the DNA.
  • kits can readily be supplied for carrying out the test of the present invention in any clinical laboratory or even in the field.
  • a kit contains a supply of supports for the samples and a supply of labelled DNA specimens from known organisms.
  • a more complete kit would include a supply of aqueous alkali at least 0.2 M in concentration, and a supply of aqueous buffer.
  • One or more standards may also be included in the kit in the form of a separate supply of DNA from a known source, preferably spotted or immobilized at a known location on the supports, as well as supplies of hybridization buffer and washing buffer solutions, and if desired a supply of photographic film for use with radioactivly labelled DNA specimens.
  • any known labels can be employed for the DNA specimens; standard radioactive labelling, as with tritium or P, makes it possible to use conventional scintillation counters for rapid and accurate determination of hybridization or to use photographic film for autoradiographic determination. Sensitivity of the test is such that samples containing no more than 1000 organisms and in some cases as few as 300 organisms can readily be identified by the present invention.
  • the invention can be used for identification of microorganisms in a sample of any culture or product containing the microorganisms in sufficient concentration so that a sample of convenient size for immobilizing upon a support contains at least the minimum detectable number of microorganisms.
  • the invention can also be used for diagnosis or identification of any disease in which the infectious organisms are sufficiently numerous so that a tissue or blood sample of practical size, say 0.1 g, contains at least the minimum detectable number of organisms.
  • diseases include leishmaniasis, malaria, trypanosomiasis, babesiasis, and herpesvirus diseases.
  • leishmaniasis, malaria, trypanosomiasis, babesiasis, and herpesvirus diseases are intended to illustrate the nature of the invention without acting as limitations upon its scope.
  • Example Sample Preparation Animals either Balb/c mice or Golden Syrian hamsters, were infected by subcutaneous infections in the rear hind foot pads of 10 to 10 promastigotes of leishmania.
  • Tissue samples for touch preparations were prepared from animals previously infected with either Leishmania mexicana or Leishmania braziliensis promastigotes. The lesion was excised two to three months after infection, the skin was removed and the tissue cut into 2-3 mm pieces. A single tissue piece was used for each touch preparation on nitrocellulose. The tissue was placed on the nitrocellulose filter for a period of 30 seconds to one minute. The nitrocellulose filter was air-dried and placed in a clean envelope for dry storage until the filter could be processed.
  • the nitrocellulose filter was treated with aqueous 0.5 M NaOH, 1.5 M NaCl solution for 10 minutes at room temperature to expose the DNA, followed by a 10 minute treatment in 3 M Tris-HCl buffer solution, pH 8, at room temperature to remove the alkali.
  • the filter was then air-dried and baked at 80°C for one hour.
  • the cells (10 ) in each case were pelleted, washed 2 times in phosphate buffered saline and the kDNA was extracted by resuspending the cells in iysis buffer (0.2 M Nacl, 0.01 M Tris, 0.001 M EDTA, pH 8.0, 10% SDS) , then shearing the chromosomal DNA by passage through a 22 gauge needle; the catenated kDNA was pelleted at 38,000 g for 30 minutes. The pellet was resuspended in a minumum volume of buffer or H 2 0, and cesium chloride was added to bring to a final concentration of 1.7 g/ml. The DNA suspension was then centrifuged for 48 hours at 40,000 rpm.
  • iysis buffer 0.2 M Nacl, 0.01 M Tris, 0.001 M EDTA, pH 8.0, 10% SDS
  • Fractions (200 ⁇ l) were collected from the bottom of the gradient. The DNA was visualized by mixing 10 1 of each fraction with 10 ⁇ 1 of ethidium bromide (1 ⁇ g/ ⁇ l) and viewed using a source of ultraviolet light. The kDNA fraction was pooled, and dialyzed overnight against 10 mM Tris-Cl pH 8.0, 1 mM EDTA (2 x 4L) .
  • Purified kDNA specimens (0.2-0.4 ⁇ g) were labelled by the method of nick translation in a 50 1 reacvtion mixture containing 50 mM NaCl, 10 mM MgCl 2 . 10 mM dithiothreitol, 125 p moles of each deoxynucleotide triphosphate (in most reactions, two radioactive ( 32P) deoxynucleotide triphosphates were used), and 12 units of DNA polymerase I. The reaction mixture was incubated at 15 ⁇ C for two hours. The labelled DNA was separated from unincorporated dATP on a chromatographic gel column run in deionized water.
  • the labelled DNA was denatured by boiling for three minutes and chilled on ice immediately before adding to the hybridization mix described below.
  • DNA from the sample lesions was immobilized were each soaked for 2 hours at 40°C in hybridization solution (50% formamide, 5 x SSC, 10 x Denhardts, 100 Vig/ml
  • OMPI denatured Salmon sperm DNA to which labelled k-DNA from a selected species of organism was added, then incubated for 12 hours at 42°C, washed in 0.1 x SSC with 0.5% SDS three times for 30 min. at 50°C. Each filter paper was air dried and exposed to XAR-5 film to provide an autoradiograph.

Abstract

Rapid identification of a microorganism is achieved by hybridization of DNA from a sample containing whole microorganisms with a kabelled specimen of species-specific substantially non-cross-hybridizing DNA from a known microorganism. Diseases characterized by localized concentrations of infectious microorganisms are rapidly diagnosed. A kit for carrying out identifications is provided.

Description

IDENTIFICATION OF MICROORGANISMS
The invention described herein.was made with Federal Government support and the Government has certain rights in the invention.
This invention relates to identification of a specific microorganism in a specimen or sample containing whole microorganisms and pertains more specifically to the diagnosis of diseases characterized by a localized concentration of infectious organisms in tissue, particularly the skin, or in a biological' fluid, particularly blood; still more particularly it pertains to the rapid diagnosis of such diseases as leishmaniasis, malaria, trypanosomiasis, babesiasis, and herpesvirus diseases.
In the culturing of microorganisms during the manufacture of such products as pharmaceuticals, e.g. antibiotics, beer, cheese, and the like, it is important to avoid contamination by alien and undesired strains of microorganisms, the presence of which has an adverse effect upon the desired product, and to determine as rapidly as possible the identity of any contaminating strains which may be present. Moreover, there are various classes of diseases each of which is generally characterized by objective symptoms but which may be caused by any one or more of several different closely related infectious organisms. Among such diseases are leishmaniasis (caused by several different species of Leishmania) , malaria (caused by several different species of Plasmodium) , trypanosomiasis (caused by several different species of Trypansoma) , babesiasis (caused by various species of Babesia) , and the diseases caused by various members of the herpesvirus family. The severity and pathogenicity of the disease in each case depends upon the specific identity of the infectious organism. Both the
OMPI
Sty iro treatment for the disease and the subsequent medical follow up depend upon rapid, accurate identification of the infecting species. Techniques currently widely used for identification of strains of microorganisms and diagnosis and identification of the infecting species in the case of diseases are time-consuming, involving the isolation and cultivation of the microorganism, e.g. the infectious organism and are often unsuccessful because of serious technical difficulties. Delay in identification is particularly serious in the case of those diseases which are endemic to areas where medical services are not readily available.
It has been proposed by Barker et al., Molec. and Biochem. Parasitology, Vol. 3, 33-46 (1981) and Arnot et a., idem, 47-56 to identify Leishmania organisms by culturing organisms from cutaneous lesions, isolating from the cultures kinetoplast DNA (kDNA) , subjecting it to digestion with a restriction enzyme, then subjecting it to hybridization with labelled kDNA from a known organism. However, specific cross hybridization between three different species was reporte .
Ostrow et al.. Virology, Vol. 108, 21-27 (1981) described extraction and purification of virus from wart tissue, extraction and purification of DNA from the purified virus, and treatment of the purified DNA with restriction enzyme followed by hybridization with labelled DNA from known organisms. Brautigam et al., J. Clin. Microbiology, vol.
12, 226-234 (1980) described, culturing of cells infected with herpes simplex virus, isolation of DNA from the culture, and hybridization with labelled DNA from a known virus. Substantial cross-reactivity between species was reported, requiring quantitative determination of extent of hybridization for identification.
It has now been found that species of microorganisms can be identified in samples of products or in samples of infected tissue or of biological fluid such as blood from infected mammals by immobilizing DNA from said sample on a solid support, subjecting said immobilized DNA to hybridization with a labeled specimen of species-specific non-cross-hybridizing DNA from a known organism, and determining whether hybridization occurs.
Despite the immobilization on the support of all DNA from all of the whole microorganisms present as well as that from the host cells of the sample, when such host cells are present, and despite the lack of any purification step and the omission of any restriction enzyme treatment, no interference occurs either from other non-specific DNA in the microorganisms or from the DNA of the host cells; further, selection for labelling of an appropriate DNA specimen from a gene library for the desired species using conventional hybridization procedures as the criteria for selection, ensures minimal cross-reactivity of DNA between species. In the case of Kinetoplastida such as Leishmania and Trypanosomes, kinetoplast DNA (kDNA) is a species-specific non-cross-hybridizing DNA which can be used effectively as the labelled probe or hybridizing agent. in practicing the invention, a sample of the product or culture suspected to contain an undesired microorganism, or a sample of infected tissue from a skin lesion or a sample of infected blood, both of which contain whole organisms of the infecting species, is simply touched momentarily to any conventional solid support for immobilizing DNA, such as
OMτi ^SNATlθ diazobenzyloxymethyl paper, a nitrocellulose filter, or a solid DNA support sold under the trade name "Gene Screen", treated with aqueous alkali (preferably at least 0.2 M) to expose the DNA from within the organism, and the alkali removed by washing. The sample DNA thus immobilized in a small localized zone of the support and containing all of the DNA of the sample, is then subjected to hybridization with a labelled specimen of species-specific non-cross-hybridizing DNA from an authentic known specimen of an individual species or subspecies of the microorganism. This can be accomplished by contacting the immobilized DNA with the labelled specimen under conventional hybridizing conditions, removing excess non-hybridized labelled specimen, for example by washing, then determining whether any labelled DNA remains hybridized to the immobilized sample. By using a labelled DNA specimen from each of the suspected microorganisms or from each of the known infectious species of organism for each disease, the identity of the causative organism is readily and quickly established by the present invention, since several hybridizations with different labelled DNA specimens can be conducted with separate test samples simultaneously.
When diazobenzyloxymethyl paper is used as the support, immobilization of the DNA occurs simply upon contact of the sample with the support, treatment of the support with aqueous alkali, and washing to remove the alkali. In the case of other supports such as nitrocellulose filters and "Gene Screen" heating to a temperature of at least 50°C for one-half hour or more is preferred as an additional step to ensure bonding or immobilization of the available DNA to the support; lower temperatures can be used but require undesirably long times; higher temperatures up to 90°C or more
OMPI require shorter times, but much higher temperatures tend to destroy the DNA.
Because of the simplicity of the procedure, a kit can readily be supplied for carrying out the test of the present invention in any clinical laboratory or even in the field. Such a kit contains a supply of supports for the samples and a supply of labelled DNA specimens from known organisms. A more complete kit would include a supply of aqueous alkali at least 0.2 M in concentration, and a supply of aqueous buffer. One or more standards may also be included in the kit in the form of a separate supply of DNA from a known source, preferably spotted or immobilized at a known location on the supports, as well as supplies of hybridization buffer and washing buffer solutions, and if desired a supply of photographic film for use with radioactivly labelled DNA specimens.
Any known labels can be employed for the DNA specimens; standard radioactive labelling, as with tritium or P, makes it possible to use conventional scintillation counters for rapid and accurate determination of hybridization or to use photographic film for autoradiographic determination. Sensitivity of the test is such that samples containing no more than 1000 organisms and in some cases as few as 300 organisms can readily be identified by the present invention. The invention can be used for identification of microorganisms in a sample of any culture or product containing the microorganisms in sufficient concentration so that a sample of convenient size for immobilizing upon a support contains at least the minimum detectable number of microorganisms. The invention can also be used for diagnosis or identification of any disease in which the infectious organisms are sufficiently numerous so that a tissue or blood sample of practical size, say 0.1 g, contains at least the minimum detectable number of organisms. Such diseases, as pointed out above, include leishmaniasis, malaria, trypanosomiasis, babesiasis, and herpesvirus diseases. The following examples are intended to illustrate the nature of the invention without acting as limitations upon its scope.
Example Sample Preparation Animals, either Balb/c mice or Golden Syrian hamsters, were infected by subcutaneous infections in the rear hind foot pads of 10 to 10 promastigotes of leishmania. Tissue samples for touch preparations were prepared from animals previously infected with either Leishmania mexicana or Leishmania braziliensis promastigotes. The lesion was excised two to three months after infection, the skin was removed and the tissue cut into 2-3 mm pieces. A single tissue piece was used for each touch preparation on nitrocellulose. The tissue was placed on the nitrocellulose filter for a period of 30 seconds to one minute. The nitrocellulose filter was air-dried and placed in a clean envelope for dry storage until the filter could be processed. The nitrocellulose filter was treated with aqueous 0.5 M NaOH, 1.5 M NaCl solution for 10 minutes at room temperature to expose the DNA, followed by a 10 minute treatment in 3 M Tris-HCl buffer solution, pH 8, at room temperature to remove the alkali. The filter was then air-dried and baked at 80°C for one hour.
Labelled k-DNA Preparation Promastigotes of Leishmania species were cultured in Schneider's Drosophila Medium supplemented with 15 percent heat reactivated fetal calf serum. The stocks of leishmania included several subspecies each of L. tropica, L. mexicana and L. braziliensis. The cells (10 ) in each case were pelleted, washed 2 times in phosphate buffered saline and the kDNA was extracted by resuspending the cells in iysis buffer (0.2 M Nacl, 0.01 M Tris, 0.001 M EDTA, pH 8.0, 10% SDS) , then shearing the chromosomal DNA by passage through a 22 gauge needle; the catenated kDNA was pelleted at 38,000 g for 30 minutes. The pellet was resuspended in a minumum volume of buffer or H20, and cesium chloride was added to bring to a final concentration of 1.7 g/ml. The DNA suspension was then centrifuged for 48 hours at 40,000 rpm. Fractions (200 μl) were collected from the bottom of the gradient. The DNA was visualized by mixing 10 1 of each fraction with 10 μ1 of ethidium bromide (1 μg/ μl) and viewed using a source of ultraviolet light. The kDNA fraction was pooled, and dialyzed overnight against 10 mM Tris-Cl pH 8.0, 1 mM EDTA (2 x 4L) .
Purified kDNA specimens (0.2-0.4 μg) were labelled by the method of nick translation in a 50 1 reacvtion mixture containing 50 mM NaCl, 10 mM MgCl2. 10 mM dithiothreitol, 125 p moles of each deoxynucleotide triphosphate (in most reactions, two radioactive ( 32P) deoxynucleotide triphosphates were used), and 12 units of DNA polymerase I. The reaction mixture was incubated at 15βC for two hours. The labelled DNA was separated from unincorporated dATP on a chromatographic gel column run in deionized water.
The labelled DNA was denatured by boiling for three minutes and chilled on ice immediately before adding to the hybridization mix described below.
Hybridization
The nitrocellulose filter papers on which the
DNA from the sample lesions was immobilized were each soaked for 2 hours at 40°C in hybridization solution (50% formamide, 5 x SSC, 10 x Denhardts, 100 Vig/ml
OMPI denatured Salmon sperm DNA) to which labelled k-DNA from a selected species of organism was added, then incubated for 12 hours at 42°C, washed in 0.1 x SSC with 0.5% SDS three times for 30 min. at 50°C. Each filter paper was air dried and exposed to XAR-5 film to provide an autoradiograph.
In each case the sample DNA from the lesion hybridized with a labelled specimen of kDNA from the same Leishmania species as the one with which the animal had been infected. No cross hybridization was observed between any subspecies of L. mexicana and L. braziliensis, and cross hybridization between subspecies of L. mexicana and L. tropica did not exceed 1%. Even this minor extent of cross hybridization was eliminated by adding unlabelled kDNA from L. tropica in 40-fold excess to the labelled probe from L. mexicana before hybridization with the immobilized sample. Such cross-hybridization was also eliminated by adding unlabelled kDNA from L. mexicana to the labelled probe from L. tropica before hybridization.
Similar results can be obtained in the case of other diseases caused by organisms of the kinetoplastida such as pathogenic South American trypanosomes as well as in the case of products such as pharmaceuticals, beer, cheese, and the like made by means of microorganisms.
What is claimed is:
-^JREA"
OMPI io

Claims

1. In a method of identifying species of microorganisms in a sample containing a mixture of microorganisms, the steps comprising immobilizing on a solid support the DNA from a sample containing said microorganisms, subjecting said immobilized DNA to hybridization with a labelled specimen of species-specific substantially non-cross-hybridizing DNA from a known microorganism, and observing whether hybridization between said immobilized DNA and said labelled specimen occurs.
2. A method as claimed in claim 1 in which said microorganism is an infectious agent and said sample comprises tissue or biological fluid containing said microorganism.
3. A method as claimed in claim 2 in which said microorganism is a kinetoplastid and said labelled specimen comprises kinetoplast DNA.
4. A method as claimed in claim 3 in which said organism is Leishmania.
5. A method as claimed in any of claims 1, 2, 3 or 4 in which the step of immobilizing comprises bringing said sample into contact with said support, treating said support with aqueous alkali, and removing said aqueous alkali from said support.
6. A kit for identifying species of microorganisms comprising a solid support for immobilizing the DNA from a sample containing said microorganisms, and at least one- labelled specimen of species-specific substantially non-cross-hybridizing DNA from a known microorganism.
7. A kit as claimed in claim 6 in which said microorganism is an infectious agent causing a class of diseases and said sample comprises tissue or biological fluid containing said microorganism.
8. A kit as claimed in claim 7 in which said microorganisms are kinetoplastids and said labelled specimen comprises kinetoplast DNA.
9. A kit as claimed in claims 6, 7 or 8 comprising in addition a supply of aqueous alkali at least 0.2 M and a supply of aqueous buffer.
PCT/US1983/001029 1982-09-20 1983-07-05 Identification of microorganisms WO1984001174A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42012982A 1982-09-20 1982-09-20

Publications (1)

Publication Number Publication Date
WO1984001174A1 true WO1984001174A1 (en) 1984-03-29

Family

ID=23665202

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1983/001029 WO1984001174A1 (en) 1982-09-20 1983-07-05 Identification of microorganisms

Country Status (2)

Country Link
EP (1) EP0119209A1 (en)
WO (1) WO1984001174A1 (en)

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0131052A1 (en) * 1983-01-10 1985-01-16 Gen Probe Inc Method for detecting, identifying, and quantitating organisms and viruses.
EP0135108A2 (en) * 1983-08-12 1985-03-27 Rockefeller University Nucleotide hybridization assay for protozoan parasites
WO1985003951A1 (en) * 1984-03-07 1985-09-12 Institut Pasteur Reagents and kits for the quantitative dosing of a viral nucleic acid in a biological medium and method for dosing said viral nucleic acid
FR2567133A1 (en) * 1984-07-06 1986-01-10 Inst Nat Sante Rech Med Process for fixing molecules, especially biological molecules, onto a support, and the filters obtained.
US4670379A (en) * 1984-12-19 1987-06-02 E. I. Du Pont De Nemours And Company Polynucleotide hydridization assays employing catalyzed luminescence
EP0235727A2 (en) * 1986-03-06 1987-09-09 Molecular Diagnostics, Inc. Rapid dna test for microbes
EP0250662A1 (en) * 1986-06-25 1988-01-07 The Regents Of The University Of California Detection of mycoplasma by DNA hybridization
EP0307270A1 (en) * 1987-08-14 1989-03-15 Institut Pasteur Bacterial diagnostic probe
EP0326989A2 (en) * 1988-01-30 1989-08-09 Kobayashi Pharmaceutical Co. Ltd. Method and kit for bacterial identification using chromosomal DNA
WO1990015881A1 (en) * 1989-06-12 1990-12-27 Cis Bio International Method for detecting specific nucleic acid sequences and applications of same
FR2650839A1 (en) * 1989-08-08 1991-02-15 Oris Ind Cie Process for the detection, in a liquid homogeneous phase, of specific sequences of nucleic acids and its applications
EP0420635A2 (en) * 1989-09-28 1991-04-03 Michael Alexander Miles Diagnostic reagents for leishmaniasis
US5541308A (en) * 1986-11-24 1996-07-30 Gen-Probe Incorporated Nucleic acid probes for detection and/or quantitation of non-viral organisms
WO1996031623A1 (en) * 1995-04-04 1996-10-10 Sumitomo Electric Industries, Ltd. Polynucleotides for detecting leishmanias and method of detection of leishmanial protozoa
US5567587A (en) * 1983-01-10 1996-10-22 Gen-Probe Incorporated Method for detecting, the presence and amount of prokaryotic organisms using specific rRNA subsequences as probes
US5714324A (en) * 1983-01-10 1998-02-03 Gen-Probe Incorporated Methods for producing hybridization probes specific for rRNA subunit subsequences
US5851767A (en) * 1985-03-04 1998-12-22 The Regents Of The University Of California Detection of prokaryotic organism by DNA hybridization
US5955261A (en) * 1984-09-04 1999-09-21 Gen-Probe Incorporated Method for detecting the presence of group-specific viral mRNA in a sample
US5994059A (en) * 1986-11-24 1999-11-30 Gen-Probe Incorporated Nucleic acid probes and methods for detecting Streptomyces enterococci
US6150517A (en) * 1986-11-24 2000-11-21 Gen-Probe Methods for making oligonucleotide probes for the detection and/or quantitation of non-viral organisms
US7087742B1 (en) 1986-11-24 2006-08-08 Gen-Probe Incorporated Oligonucleotide probes for the detection and/or quantitation of non-viral organisms
US7090972B1 (en) 1986-11-24 2006-08-15 Gen-Probe Incorporated Methods for determining the presence of non-viral organisms in a sample
US7172863B1 (en) 1988-12-09 2007-02-06 Gen-Probe Incorporated Nucleic acid probes and methods for detecting Neisseria gonorrhoeae
US9638662B2 (en) 2002-09-24 2017-05-02 Duke University Apparatuses and methods for manipulating droplets

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358535A (en) * 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
US4396713A (en) * 1980-11-12 1983-08-02 The Regents Of The University Of Calif. Restriction endonuclease fingerprinting of kinetoplast DNA minicircles

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4396713A (en) * 1980-11-12 1983-08-02 The Regents Of The University Of Calif. Restriction endonuclease fingerprinting of kinetoplast DNA minicircles
US4358535A (en) * 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
US4358535B1 (en) * 1980-12-08 1986-05-13

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
Biochemica et Biophysica Acta, 610, 1980, BORST et al, "Variations in Maxi-Circle and Mini-Circle Sequences in Kinetoplast DNAs from Different Trypanosoma Brucei Strains" p. 197-210 *
CHEMICAL ABSTRACTS Vol. 93, issued 1980, page 221, Abstract Number 199423p, BORST et al, "Characterization of DNA from Trypanosoma Brucei and Related Trypanosomes ..." *
Journal of Clinical Medicine, 12(2), August 1980, BRAUTIGAM et al, "Rapid Typing of Simplex Virus Isolates by Deoxyribonucleic Acid: Deoxyribonucleic Acid Hybridization" p. 226-34 *
Molecular and Biochemical Parasitology, 3 1981, ARNOT et al, "Biochemical Indentification of Cutaneous Leishmanias by Analysis of Kinetoplast Dna. II" p. 45-56 *
Molecular and Biochemical Parasitology, 3 1981, BARKER et al, "Biochemical Identification of Cutaneous Leishmanias by Analysis of Kinetoplast Dna I" p. 33-46 *
Proceedings of the National Academy of Sciences USA, 79, November 1982, WIRTH et al, "Rapid Identification of Leishmania Species by Specific Hybridization of Kinetoplast Dna in Cutaneous Lesions", p. 6999-7003 *
Virology, 108, 1981, OSTROW et al, "Identification of A Nevel Human Papilloma Virus in Cutaneous Warts of Meathandlers", p. 21-7 *

Cited By (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5738988A (en) * 1983-01-10 1998-04-14 Gen-Probe Incorporated Method for detecting antimicrobial agents or unknown organisms in a sample using ribosomal probe hybridization
US5723597A (en) * 1983-01-10 1998-03-03 Gen-Probe Incorporated Ribosomal nucleic acid probes for detecting organisms or groups of organisms
US5932416A (en) * 1983-01-10 1999-08-03 Gen Probe Inc Method for detecting the presence of RNA belonging to an organ or tissue cell-type
US5567587A (en) * 1983-01-10 1996-10-22 Gen-Probe Incorporated Method for detecting, the presence and amount of prokaryotic organisms using specific rRNA subsequences as probes
US5641631A (en) * 1983-01-10 1997-06-24 Gen-Probe Incorporated Method for detecting, identifying, and quantitating organisms and viruses
US5641632A (en) * 1983-01-10 1997-06-24 Gen-Probe Incorporated Method for preparing rRNA for hybridization with a probe
US5688645A (en) * 1983-01-10 1997-11-18 Gen-Probe Incorporated Method for detecting, identifying, and quantitating non-viral organisms
US5928864A (en) * 1983-01-10 1999-07-27 Gen-Probe Incorporated Method for determining the presence of organisms in a sample by detecting transfer nucleic acid
US5714324A (en) * 1983-01-10 1998-02-03 Gen-Probe Incorporated Methods for producing hybridization probes specific for rRNA subunit subsequences
US5601984A (en) * 1983-01-10 1997-02-11 Gen-Probe Incorporated Method for detecting, the presense or amount of a taxonomic group of organisms using specific R-RNA subsequences as probes
US5738989A (en) * 1983-01-10 1998-04-14 Gen-Probe Incorporated Method for determining the sensitivity of microorganisms to anti microbial agents using ribosomal nucleic acid hybridization
EP0131052A1 (en) * 1983-01-10 1985-01-16 Gen Probe Inc Method for detecting, identifying, and quantitating organisms and viruses.
EP0131052A4 (en) * 1983-01-10 1987-09-08 Gen Probe Inc Method for detecting, identifying, and quantitating organisms and viruses.
EP0135108A3 (en) * 1983-08-12 1988-07-13 Rockefeller University Nucleotide hybridization assay for protozoan parasites
EP0135108A2 (en) * 1983-08-12 1985-03-27 Rockefeller University Nucleotide hybridization assay for protozoan parasites
EP0159223A1 (en) * 1984-03-07 1985-10-23 Institut Pasteur Reagents and kits for the quantitative analysis of a viral nucleic acid in a biological medium and method for the analysis of this viral nucleic acid
WO1985003951A1 (en) * 1984-03-07 1985-09-12 Institut Pasteur Reagents and kits for the quantitative dosing of a viral nucleic acid in a biological medium and method for dosing said viral nucleic acid
FR2560995A1 (en) * 1984-03-07 1985-09-13 Pasteur Institut REAGENTS AND KITS FOR THE QUANTITATIVE DETERMINATION OF A VIRAL NUCLEIC ACID IN A BIOLOGICAL MEDIUM AND METHOD FOR DETERMINING SUCH A VIRAL NUCLEIC ACID
FR2567133A1 (en) * 1984-07-06 1986-01-10 Inst Nat Sante Rech Med Process for fixing molecules, especially biological molecules, onto a support, and the filters obtained.
US5955261A (en) * 1984-09-04 1999-09-21 Gen-Probe Incorporated Method for detecting the presence of group-specific viral mRNA in a sample
US4670379A (en) * 1984-12-19 1987-06-02 E. I. Du Pont De Nemours And Company Polynucleotide hydridization assays employing catalyzed luminescence
US5851767A (en) * 1985-03-04 1998-12-22 The Regents Of The University Of California Detection of prokaryotic organism by DNA hybridization
EP0235727A2 (en) * 1986-03-06 1987-09-09 Molecular Diagnostics, Inc. Rapid dna test for microbes
EP0235727A3 (en) * 1986-03-06 1990-02-14 Molecular Diagnostics, Inc. Rapid dna test for microbes
EP0250662A1 (en) * 1986-06-25 1988-01-07 The Regents Of The University Of California Detection of mycoplasma by DNA hybridization
US5840488A (en) * 1986-11-24 1998-11-24 Gen-Probe Incorporated Nucleic acid probes for detection and/or quantitation of non-viral organisms
US5958679A (en) * 1986-11-24 1999-09-28 Gen-Probe Incorporated Nucleic acid probes and methods for detecting Enterobacter cloacae
US7138516B1 (en) 1986-11-24 2006-11-21 Gen-Probe Incorporated Oligonucleotide probes for the detection and/or quantitation of non-viral organisms
US5547842A (en) * 1986-11-24 1996-08-20 Gen-Probe Incorporated Nucleic acid probes for detection and/or quantitation of non-viral organisms
US5674684A (en) * 1986-11-24 1997-10-07 Gen-Probe Incorporated Nucleic acid probes and methods for detecting campylobacters
US5677127A (en) * 1986-11-24 1997-10-14 Gen-Probe Incorporated Nucleic acid probes and methods for detecting group I pseudomonas
US5677128A (en) * 1986-11-24 1997-10-14 Gen-Probe Incorporated Nucleic acid probes and methods for detecting mycobacterium
US5677129A (en) * 1986-11-24 1997-10-14 Gen-Probe Incorporated Nucleic acid probes and methods for detecting legionella
US5679520A (en) * 1986-11-24 1997-10-21 Gen-Probe Incorporated Nucleic acid probes and methods for detecting eubacteria
US5683876A (en) * 1986-11-24 1997-11-04 Gen-Probe Incorporated Nucleic acid probes and methods for detecting Proteus mirabilis
US5541308A (en) * 1986-11-24 1996-07-30 Gen-Probe Incorporated Nucleic acid probes for detection and/or quantitation of non-viral organisms
US5691149A (en) * 1986-11-24 1997-11-25 Gen-Probe Incorporated Nucleic acid probes and method for detecting Mycoplasma pneumoniae
US5693469A (en) * 1986-11-24 1997-12-02 Gen-Probe Incorporated Nucleic acid probes and methods for detecting Escherichia coli
US5693468A (en) * 1986-11-24 1997-12-02 Gen-Probe Incorported Nucleic acid probes and methods for detecting chlamydia trachomatis
US7090972B1 (en) 1986-11-24 2006-08-15 Gen-Probe Incorporated Methods for determining the presence of non-viral organisms in a sample
US7087742B1 (en) 1986-11-24 2006-08-08 Gen-Probe Incorporated Oligonucleotide probes for the detection and/or quantitation of non-viral organisms
US6512105B1 (en) 1986-11-24 2003-01-28 Gen-Probe Incorporated Methods for making oligonucleotide probes for the detection and/or quantitation of non-viral organisms
US6150517A (en) * 1986-11-24 2000-11-21 Gen-Probe Methods for making oligonucleotide probes for the detection and/or quantitation of non-viral organisms
US5827651A (en) * 1986-11-24 1998-10-27 Gen-Probe Incorporated Nucleic acid probes and methods for detecting fungi
US5994059A (en) * 1986-11-24 1999-11-30 Gen-Probe Incorporated Nucleic acid probes and methods for detecting Streptomyces enterococci
US5593841A (en) * 1986-11-24 1997-01-14 Gen-Probe Incorporated Nucleic acid probes for detection and/or quantitation of non-viral organisms
US6017711A (en) * 1987-08-14 2000-01-25 Institut Pasteur Bacterial diagnostic probe
US5863721A (en) * 1987-08-14 1999-01-26 Institut Pasteur Bacterial diagnostic probe
US5492811A (en) * 1987-08-14 1996-02-20 Institut Pasteur Bacterial diagnostic probe
EP0307270A1 (en) * 1987-08-14 1989-03-15 Institut Pasteur Bacterial diagnostic probe
EP0326989A3 (en) * 1988-01-30 1991-01-02 Kobayashi Pharmaceutical Co. Ltd. Method and kit for bacterial identification using chromosomal dna
EP0326989A2 (en) * 1988-01-30 1989-08-09 Kobayashi Pharmaceutical Co. Ltd. Method and kit for bacterial identification using chromosomal DNA
US7172863B1 (en) 1988-12-09 2007-02-06 Gen-Probe Incorporated Nucleic acid probes and methods for detecting Neisseria gonorrhoeae
WO1990015881A1 (en) * 1989-06-12 1990-12-27 Cis Bio International Method for detecting specific nucleic acid sequences and applications of same
US5514540A (en) * 1989-06-12 1996-05-07 Cis Bio International Method for detecting specific nucleic acid sequences by amplification in highly dilute solution
FR2650839A1 (en) * 1989-08-08 1991-02-15 Oris Ind Cie Process for the detection, in a liquid homogeneous phase, of specific sequences of nucleic acids and its applications
EP0420635A2 (en) * 1989-09-28 1991-04-03 Michael Alexander Miles Diagnostic reagents for leishmaniasis
EP0420635A3 (en) * 1989-09-28 1992-05-27 Michael Alexander Miles Diagnostic reagents for leishmaniasis
US6022690A (en) * 1995-04-04 2000-02-08 Sumitomo Electric Industries, Ltd. Polynucleotides for detecting leishmanias and method of detection of leishmanial protozoan
WO1996031623A1 (en) * 1995-04-04 1996-10-10 Sumitomo Electric Industries, Ltd. Polynucleotides for detecting leishmanias and method of detection of leishmanial protozoa
US9638662B2 (en) 2002-09-24 2017-05-02 Duke University Apparatuses and methods for manipulating droplets

Also Published As

Publication number Publication date
EP0119209A1 (en) 1984-09-26

Similar Documents

Publication Publication Date Title
WO1984001174A1 (en) Identification of microorganisms
US4994373A (en) Method and structures employing chemically-labelled polynucleotide probes
Tham et al. Detection and species determination of malaria parasites by PCR: comparison with microscopy and with ParaSight-F and ICT malaria Pf tests in a clinical environment
EP1080228B1 (en) In situ hybridization method for detecting target nucleic acid
Zhong et al. A PCR assay for the detection of Wuchereria bancrofti in blood
Weiss DNA probes and PCR for diagnosis of parasitic infections
US4358535A (en) Specific DNA probes in diagnostic microbiology
Brenière et al. Different Behavior of TwoTrypanosoma cruziMajor Clones: Transmission and Circulation in Young Bolivian Patients
US6238866B1 (en) Detector for nucleic acid typing and methods of using the same
Vitale et al. Detection of Mycobacterium tuberculosis complex in cattle by PCR using milk, lymph node aspirates, and nasal swabs
Adhya et al. Detection of Leishmania in the blood of early kala-azar patients with the aid of the polymerase chain reaction
EP0336454B1 (en) Nucleic acid hybridization assay
Andresen et al. Diagnosis of visceral leishmaniasis by the polymerase chain reaction using blood, bone marrow and lymph node samples from patients from the Sudan
Wilson DNA-based methods in the detection of Leishmania parasites: field applications and practicalities
Spathas et al. Prenatal detection of trisomy 21 in uncultured amniocytes by fluorescence in situ hybridization: a prospective study
JPH07505535A (en) A nucleotide sequence that specifically hybridizes with the base sequence of a nucleic acid in the genome of Campylobacter jejuni
US4801530A (en) Nucleotide hybridization assay for protozoan parasites
US20100240027A1 (en) Surrogate Markers for Viral Infections and Other Inflammatory Responses
Dukes et al. Elusive trypanosomes
Nantulya Molecular diagnosis of parasites
US6156505A (en) Specific DNA probes for the identification of the Taenia solium and Taenia saginata species
WO1993003184A1 (en) Method for detecting lyme disease and composition
JPH03206899A (en) Nucleic acid probe and method for use in detection of cryptocox neoholmance
Zhang et al. Paper chromatography hybridization: a rapid method for detection of Onchocerca volvulus DNA amplified by PCR.
Smits et al. PCR amplification reactions in parasitology

Legal Events

Date Code Title Description
AK Designated states

Designated state(s): JP

AL Designated countries for regional patents

Designated state(s): AT BE CH DE FR GB LU NL SE